These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 29180094)

  • 1. Validation study of the Vitiligo Extent Score-plus.
    van Geel N; Wolkerstorfer A; Lommerts JE; Ezzedine K; Eleftheriadou V; Hamzavi I; Harris J; Picardo M; Taieb A; Prinsen CAC; Bekkenk M; Speeckaert R
    J Am Acad Dermatol; 2018 May; 78(5):1013-1015. PubMed ID: 29180094
    [No Abstract]   [Full Text] [Related]  

  • 2. The Vitiligo Extent Score (VES) and the VESplus are responsive instruments to assess global and regional treatment response in patients with vitiligo.
    van Geel N; Bekkenk M; Lommerts JE; Ezzedine K; Harris J; Hamzavi I; Eleftheriadou V; Picardo M; Taieb A; Prinsen CAC; Wolkerstorfer A; Speeckaert R
    J Am Acad Dermatol; 2018 Aug; 79(2):369-371. PubMed ID: 29307645
    [No Abstract]   [Full Text] [Related]  

  • 3. Topical tacrolimus may enhance repigmentation with targeted narrowband ultraviolet B to treat vitiligo: a randomized, controlled study.
    Klahan S; Asawanonda P
    Clin Exp Dermatol; 2009 Dec; 34(8):e1029-30. PubMed ID: 20055831
    [No Abstract]   [Full Text] [Related]  

  • 4. Tetrahydrocurcuminoid cream plus targeted narrowband UVB phototherapy for vitiligo: a preliminary randomized controlled study.
    Asawanonda P; Klahan SO
    Photomed Laser Surg; 2010 Oct; 28(5):679-84. PubMed ID: 20961233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tacalcitol and narrow-band phototherapy in patients with vitiligo.
    Leone G; Pacifico A; Iacovelli P; Paro Vidolin A; Picardo M
    Clin Exp Dermatol; 2006 Mar; 31(2):200-5. PubMed ID: 16487090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An open randomized study to compare narrow band UVB, topical pimecrolimus and topical tacrolimus in the treatment of vitiligo.
    Stinco G; Piccirillo F; Forcione M; Valent F; Patrone P
    Eur J Dermatol; 2009; 19(6):588-93. PubMed ID: 19651562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of vitiligo with topical 15% lactic acid solution in combination with ultra violet-A.
    Bukhari IA
    Saudi Med J; 2005 Dec; 26(12):2011; author reply 2011. PubMed ID: 16380801
    [No Abstract]   [Full Text] [Related]  

  • 8. Narrow-band UVB311 nm vs. broad-band UVB therapy in combination with topical calcipotriol vs. placebo in vitiligo.
    Hartmann A; Lurz C; Hamm H; Bröcker EB; Hofmann UB
    Int J Dermatol; 2005 Sep; 44(9):736-42. PubMed ID: 16135141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Automated scoring of vitiligo using superpixel-generated computerized digital image analysis of clinical photographs: a novel and consistent way to score vitiligo.
    Toh JJH; Bhoi S; Tan VWD; Chuah SY; Jhingan A; Kong AWK; Thng STG
    Br J Dermatol; 2018 Jul; 179(1):220-221. PubMed ID: 29573393
    [No Abstract]   [Full Text] [Related]  

  • 10. Repigmentation of acrofacial vitiligo with subcutaneous tildrakizumab.
    Jerjen R; Moodley A; Sinclair R
    Australas J Dermatol; 2020 Nov; 61(4):e446-e448. PubMed ID: 32441048
    [No Abstract]   [Full Text] [Related]  

  • 11. Topical calcipotriene and narrowband ultraviolet B in the treatment of vitiligo.
    Kullavanijaya P; Lim HW
    Photodermatol Photoimmunol Photomed; 2004 Oct; 20(5):248-51. PubMed ID: 15379875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of narrow band UVB and topical calcipotriol for the treatment of vitiligo.
    Goktas EO; Aydin F; Senturk N; Canturk MT; Turanli AY
    J Eur Acad Dermatol Venereol; 2006 May; 20(5):553-7. PubMed ID: 16684283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of vitiligo with the topical Janus kinase inhibitor ruxolitinib: A 32-week open-label extension study with optional narrow-band ultraviolet B.
    Joshipura D; Alomran A; Zancanaro P; Rosmarin D
    J Am Acad Dermatol; 2018 Jun; 78(6):1205-1207.e1. PubMed ID: 29438765
    [No Abstract]   [Full Text] [Related]  

  • 14. Low-dose UVB therapy is comparable with conventional UVB phototherapy for treatment of vitiligo: A pilot study.
    Chiu SH; Liu IL; Chen YW; Lan CE
    J Dermatol Sci; 2018 Nov; 92(2):218-220. PubMed ID: 30227989
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of narrow band ultraviolet B phototherapy as monotherapy or combination therapy for vitiligo: a meta-analysis.
    Li R; Qiao M; Wang X; Zhao X; Sun Q
    Photodermatol Photoimmunol Photomed; 2017 Jan; 33(1):22-31. PubMed ID: 27696531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitiligo: new and emerging treatments.
    Lotti T; Gori A; Zanieri F; Colucci R; Moretti S
    Dermatol Ther; 2008; 21(2):110-7. PubMed ID: 18394085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, double-blinded, placebo-controlled trial of pseudocatalase cream and narrowband ultraviolet B in the treatment of vitiligo.
    Bakis-Petsoglou S; Le Guay JL; Wittal R
    Br J Dermatol; 2009 Oct; 161(4):910-7. PubMed ID: 19523170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitiligo Potential Repigmentation Index: a simple clinical score that might predict the ability of vitiligo lesions to repigment under therapy.
    Benzekri L; Ezzedine K; Gauthier Y
    Br J Dermatol; 2013 May; 168(5):1143-6. PubMed ID: 23464539
    [No Abstract]   [Full Text] [Related]  

  • 19. New and experimental treatments of vitiligo and other hypomelanoses.
    Lotti T; Prignano F; Buggiani G
    Dermatol Clin; 2007 Jul; 25(3):393-400, ix. PubMed ID: 17662905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of vitiligo with broadband ultraviolet B and vitamins.
    Don P; Iuga A; Dacko A; Hardick K
    Int J Dermatol; 2006 Jan; 45(1):63-5. PubMed ID: 16426381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.